Loading...

Home
ETF
NVS

NVS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

NVS News

Novartis' Vanrafia Trial Results Show Significant Kidney Function Improvement

2d agoNASDAQ.COM

Health Care Stocks Rise as NYSE Index Gains 1.1%

1d agoYahoo Finance

Novartis Vanrafia Study Results Support Slowing Kidney Function Decline

Global Equities Rebound, International ETFs Gain Attention

Super Bowl LX: Seahawks Defeat Patriots 29-13

Novartis Breaks Ground on San Diego Biomedical Research Center

Feb 06 2026seekingalpha

Biogen Shares Increase Despite Falling Multiple Sclerosis Revenue and Ongoing Declines

Feb 06 2026Barron's

Amazon's Stock Drops Ahead of Earnings Report

Feb 05 2026CNBC

Novartis Reports Q4 2025 Results with Mixed Performance

Feb 04 2026Benzinga

Novartis Q4 2023 Earnings Report Analysis

Feb 04 2026seekingalpha

Novartis Proposes CHF 3.70 Dividend for 2025, Up 5.7%

Feb 04 2026seekingalpha

Novartis Reports Lower Q4 Profit Despite Sales Growth

Feb 04 2026NASDAQ.COM

Novartis Q4 Earnings Beat Expectations

Feb 04 2026seekingalpha

Market Movements Ahead of U.S. Mining Conference

Feb 04 2026CNBC

Novo Nordisk Shares Plunge 14.59% Amid 2026 Sales Decline Forecast

Feb 04 2026NASDAQ.COM

Novo Nordisk Shares Plunge 14.64% on 2026 Sales Forecast Downgrade

Feb 04 2026Fool